Increasing melanoma incidence with unchanged mortality: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?
Uloženo v:
| Název: | Increasing melanoma incidence with unchanged mortality: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold? |
|---|---|
| Autoři: | Nielsen, Jesper Bo, Kristiansen, Ivar Sønbø, Thapa, Subash |
| Zdroj: | British Journal of Dermatology. 191:365-374 |
| Informace o vydavateli: | Oxford University Press (OUP), 2024. |
| Rok vydání: | 2024 |
| Témata: | Male, Adult, Skin Neoplasms, Melanoma/mortality, Overdiagnosis, Adolescent, Ultraviolet Rays, Denmark, Biopsy, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Ultraviolet Rays/adverse effects, Humans, Skin Neoplasms/mortality, Registries, Child, Melanoma, Aged, Incidence, Registries/statistics & numerical data, Middle Aged, Denmark/epidemiology, Overdiagnosis/statistics & numerical data, Sunlight/adverse effects, Sunlight, Female |
| Popis: | Background Increasing melanoma incidence with less increasing mortality is observed in several countries. This discrepancy is not well understood. Objectives In this study, our aim was to discuss factors [ultraviolet radiation (UVR) exposure, melanoma treatment, diagnostic activity, overdiagnosis, pathologists’ diagnostic threshold and clinicians’ propensity to remove suspect skin lesions] that might influence melanoma incidence and mortality in Denmark. Methods This was a register study with the number of melanocyte-related lesions and melanoma mortality based on comprehensive national pathology and mortality databases for the period 1999–2019. We investigated melanocyte-related diagnoses and mortality in a population of 5.5 million with a national healthcare system. Age-adjusted melanoma mortality and age-adjusted incidence of benign naevi, atypical lesion, or melanoma in situ and of invasive melanoma were computed for data analysis. Results In total, 1 434 798 biopsies were taken from 704 682 individuals (65% female). The mean age at biopsy was 39.8 years in males and 37.6 in females. In males and females, the incidence of invasive melanoma increased by 87% during the period 1999–2011. During the subsequent period it increased by 9% in males but remained unchanged in females. The incidence of melanoma in situ increased by 476% in males and 357% in females during the study period, while the increases for atypical melanocytic lesions were 1928% and 1686%, respectively. Biopsy rates increased by 153% in males and 118% in females from 1999 through 2011 but fell by 20% in males and 22% in females during the subsequent period. Mortality varied slightly from year to year without any significant time trend for males or females. We identified no evidence of increased UVR exposure over the latest 30 years in Denmark. Immunotherapy of advanced melanoma was introduced in Denmark in 2010 and came into general use in 2014. Conclusions Comprehensive national data demonstrate increasing melanoma incidence correlated with increasing biopsy rates, but with no change in mortality. Previously suggested explanations for such a trend are a lowered threshold of melanoma diagnosis among pathologists, increased diagnostic activity in the presence of overdiagnosis and improved melanoma treatment. Because the study is observational and we have more explanatory factors than outcomes, the findings do not warrant conclusions about causal relationships. |
| Druh dokumentu: | Article |
| Jazyk: | English |
| ISSN: | 1365-2133 0007-0963 |
| DOI: | 10.1093/bjd/ljae175 |
| Přístupová URL adresa: | https://pubmed.ncbi.nlm.nih.gov/38655629 |
| Rights: | CC BY |
| Přístupové číslo: | edsair.doi.dedup.....c45430883bdaf83d5e6bec3165cab1dd |
| Databáze: | OpenAIRE |
Nájsť tento článok vo Web of Science | Abstrakt: | Background Increasing melanoma incidence with less increasing mortality is observed in several countries. This discrepancy is not well understood. Objectives In this study, our aim was to discuss factors [ultraviolet radiation (UVR) exposure, melanoma treatment, diagnostic activity, overdiagnosis, pathologists’ diagnostic threshold and clinicians’ propensity to remove suspect skin lesions] that might influence melanoma incidence and mortality in Denmark. Methods This was a register study with the number of melanocyte-related lesions and melanoma mortality based on comprehensive national pathology and mortality databases for the period 1999–2019. We investigated melanocyte-related diagnoses and mortality in a population of 5.5 million with a national healthcare system. Age-adjusted melanoma mortality and age-adjusted incidence of benign naevi, atypical lesion, or melanoma in situ and of invasive melanoma were computed for data analysis. Results In total, 1 434 798 biopsies were taken from 704 682 individuals (65% female). The mean age at biopsy was 39.8 years in males and 37.6 in females. In males and females, the incidence of invasive melanoma increased by 87% during the period 1999–2011. During the subsequent period it increased by 9% in males but remained unchanged in females. The incidence of melanoma in situ increased by 476% in males and 357% in females during the study period, while the increases for atypical melanocytic lesions were 1928% and 1686%, respectively. Biopsy rates increased by 153% in males and 118% in females from 1999 through 2011 but fell by 20% in males and 22% in females during the subsequent period. Mortality varied slightly from year to year without any significant time trend for males or females. We identified no evidence of increased UVR exposure over the latest 30 years in Denmark. Immunotherapy of advanced melanoma was introduced in Denmark in 2010 and came into general use in 2014. Conclusions Comprehensive national data demonstrate increasing melanoma incidence correlated with increasing biopsy rates, but with no change in mortality. Previously suggested explanations for such a trend are a lowered threshold of melanoma diagnosis among pathologists, increased diagnostic activity in the presence of overdiagnosis and improved melanoma treatment. Because the study is observational and we have more explanatory factors than outcomes, the findings do not warrant conclusions about causal relationships. |
|---|---|
| ISSN: | 13652133 00070963 |
| DOI: | 10.1093/bjd/ljae175 |